NeoImmuneTech. 

₩1,611
0
-₩7-0.43% 01:08 Today

Statistics

Day High
1,639
Day Low
1,590
52W High
4,450
52W Low
1,115
Volume
18,062
Avg. Volume
973,370
Mkt Cap
11.02B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-33,548.5%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
94.76MRevenue
-31.79BNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
Show More
CEO
Luke Yun Suk Oh
Employees
82
Country
South Korea
ISIN
KR8840140006

Listings

0 Comments

Share your thoughts

FAQs

What is NeoImmuneTech. stock price today?▼
The current price of 950220.KQ is ₩1,611 KRW — it has decreased by -0.43% in the past 24 hours. Watch NeoImmuneTech. stock price performance more closely on the chart.
What is NeoImmuneTech. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange NeoImmuneTech. stocks are traded under the ticker 950220.KQ.
Is NeoImmuneTech. stock price growing?▼
950220.KQ stock has fallen by -4.07% compared to the previous week, the month change is a -19.29% fall, over the last year NeoImmuneTech. has showed a -41.75% decrease.
What is NeoImmuneTech. market cap?▼
Today NeoImmuneTech. has the market capitalization of 11.02B
What is NeoImmuneTech. revenue for the last year?▼
NeoImmuneTech. revenue for the last year amounts to 94.76M KRW.
What is NeoImmuneTech. net income for the last year?▼
950220.KQ net income for the last year is -31.79B KRW.
How many employees does NeoImmuneTech. have?▼
As of November 3, 2026, the company has 82 employees.
In which sector is NeoImmuneTech. located?▼
NeoImmuneTech. operates in the Health & Wellness sector.
When did NeoImmuneTech. complete a stock split?▼
The last stock split for NeoImmuneTech. was on June 10, 2026 with a ratio of 1:5.
Where is NeoImmuneTech. headquartered?▼
NeoImmuneTech. is headquartered in Rockville, South Korea.